leadf
logo-loader
viewHarvest One Cannabis Inc.

Harvest One sells United Greeneries facility for C$8.2M; reveals fiscal 3Q revenue bump

The company also plans to execute a license agreement with the facilities purchasers in exchange for a royalty

$100 bill appearing to grow from a cannabis plant
Harvest One serves as an umbrella over three wholly-owned subsidiaries: Satipharm, Dream Water and a controlling interest in Greenbelt Greenhouse.

Harvest One Cannabis Inc (CVE:HVT) (OTCQX:HRVOF) is selling its United Greeneries cannabis cultivation and processing business in Duncan, British Columbia as it transitions more into the consumer packaged goods space, the company announced Friday.

Harvest One agreed to an C$8.2 million deal with Costa Canna Production LLP and 626875 BC Ltd. The parties also plan to execute a licenses agreement, which will see Harvest One’s subsidiaries provide Costa LLP with licensed intellectual property to produce and distribute Cannabis 2.0 products in Canada. In exchange, Harvest One will receive a 95% royalty and distribution of its products.

"The agreement to sell our Duncan Facility and its related operations represents a strategic step forward for Harvest One, further divesting from its capital intensive cultivation activities and firmly establishing ourselves as a cannabis-focused CPG company," CEO Andrew Bayfield said in a statement. "We will continue to focus on expanding our core brands of LivRelief, Dream Water and Satipharm together with the commercialization of Cannabis 2.0 product offerings in Canada."

READ: Harvest One expands Satipharms proprietary Gelpell product offerings

The purchasers will also issue a pair of promissory notes to Harvest One subsidiaries representing the value of certain cannabis and other item inventories that will be calculated at closing, the company said. The deal is expected to close on June 30. 

"When complete, this transaction will significantly improve the company's overall cost structure and will provide liquidity to strengthen our balance sheet,” Bayfield said. “We are continuing to take necessary and decisive measures to streamline our operations, lower our cost structure and reduce our cash burn. I am confident we are on the right path and this transaction serves to further reinforce the company's plan to become cash flow positive in fiscal 2021."

Along with the transaction, Harvest One secured a C$1.5 million bridge financing facility from Costa which will become available once the deal is signed. The facility is meant to mature and be repaid in full, the company said.

Vancouver-based Harvest One serves as an umbrella over three wholly owned subsidiaries: Satipharm, which develops cannabis-based health products; Dream Water, which offers consumer sleep aids; and a controlling interest in Greenbelt Greenhouse.

Third quarter results

Harvest One also released its fiscal third-quarter results before the bell Friday, which showed improved revenue and a consumer division only moderately affected by the coronavirus pandemic. 

Revenue for the three months ended March 31 came in at C$3.3 million, up 10% from C$3 million in the same period last year. On a quarter-over-quarter basis, revenue jumped 88% due to higher recreational cannabis and bulk cannabis sales.  

The company’s consumer division decreased 2% quarter-over-quarter despite the impact of coronavirus in the back end of the period, the company said. 

Harvest One’s net loss was C$35 million, or C$0.16 per share, which was due primarily to C$27.5 million in non-cash goodwill impairment charges and C$1.5 million in non-cash inventory write-downs. A year earlier, that figure was C$5.1 million, or $0.03 per share. 

The company’s adjusted EBITDA, though, was a loss of C$2.4 million, compared to a C$1.6 million loss in the same period of 2019.

The company also stressed that its outlook remains promising for sales volumes in both its consumer and medical divisions for the rest of fiscal 2020 and fiscal 2021. Next quarter’s report will reflect Cannabis 2.0 sales, and the company said it has seen strong demand from its retail and provincial partners.

Harvest One is also continuing to undergo a strategic review, the results of which could possibly include the sale of its 50.1% interest in Greenbelt Greenhouse and the Lucky Lake facility. 

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Quick facts: Harvest One Cannabis Inc.

Price: 0.07 CAD

TSX-V:HVT
Market: TSX-V
Market Cap: $15.06 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Harvest One Cannabis Inc. named herein, including the promotion by the Company of Harvest One Cannabis Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Full interview: Harvest One Cannabis receives Health Canada cultivation...

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) Senior Vice President of Corporate & Public Affairs Will Stewart tells Proactive the cannabis company has earned a cannabis cultivation license from Health Canada for phase one of its Mission Road facility in Duncan, British...

on 15/10/19

3 min read